Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
Carey Business School, Johns Hopkins University, Baltimore, Maryland, United States of America.
PLoS One. 2024 Feb 28;19(2):e0290105. doi: 10.1371/journal.pone.0290105. eCollection 2024.
Pervasive differences in cancer screening among race/ethnicity and insurance groups presents a challenge to achieving equitable healthcare access and health outcomes. However, the change in the magnitude of cancer screening disparities over time has not been thoroughly examined using recent public health survey data.
A retrospective cross-sectional analysis of the 2008 and 2018 National Health Interview Survey (NHIS) database focused on breast, cervical, and colorectal cancer screening rates among race/ethnicity and insurance groups. Multivariable logistic regression models were used to assess the relationship between cancer screening rates, race/ethnicity, and insurance coverage, and to quantify the changes in disparities in 2008 and 2018, adjusting for potential confounders.
Colorectal cancer screening rates increased for all groups, but cervical and mammogram rates remained stagnant for specific groups. Non-Hispanic Asians continued to report consistently lower odds of receiving cervical tests (OR: 0.42, 95% CI: 0.32-0.55, p<0.001) and colorectal cancer screening (OR: 0.55, 95% CI: 0.42-0.72, p<0.001) compared to non-Hispanic Whites in 2018, despite significant improvements since 2008. Non-Hispanic Blacks continued to report higher odds of recent cervical cancer screening (OR: 1.98, 95% CI: 1.47-2.68, p<0.001) and mammograms (OR: 1.32, 95% CI: 1.02-1.71, p<0.05) than non-Hispanic Whites in 2018, consistent with higher odds observed in 2008. Hispanic individuals reported improved colorectal cancer screening over time, with no significant difference compared to non-Hispanics Whites in 2018, despite reporting lower odds in 2008. The uninsured status was associated with significantly lower odds of cancer screening than private insurance for all three cancers in 2008 and 2018.
Despite an overall increase in breast and colorectal cancer screening rates between 2008 and 2018, persistent racial/ethnic and insurance disparities exist among race/ethnicity and insurance groups. These findings highlight the importance of addressing underlying factors contributing to disparities among underserved populations and developing corresponding interventions.
不同种族/族裔和保险群体之间普遍存在癌症筛查差异,这对实现公平获得医疗保健和健康结果构成了挑战。然而,利用最近的公共卫生调查数据,尚未全面研究癌症筛查差异随时间的变化幅度。
对 2008 年和 2018 年国家健康访谈调查(NHIS)数据库进行回顾性横断面分析,重点关注种族/族裔和保险群体的乳腺癌、宫颈癌和结直肠癌筛查率。多变量逻辑回归模型用于评估癌症筛查率、种族/族裔和保险覆盖范围之间的关系,并量化 2008 年和 2018 年差异的变化,同时调整潜在混杂因素。
所有群体的结直肠癌筛查率均有所增加,但特定群体的宫颈癌和乳房 X 光检查率仍停滞不前。与非西班牙裔白人相比,2018 年非西班牙裔亚裔继续报告接受宫颈癌检查(OR:0.42,95%CI:0.32-0.55,p<0.001)和结直肠癌筛查(OR:0.55,95%CI:0.42-0.72,p<0.001)的可能性显著降低,尽管自 2008 年以来有显著改善。与非西班牙裔白人相比,2018 年非西班牙裔黑人继续报告更高的近期宫颈癌筛查(OR:1.98,95%CI:1.47-2.68,p<0.001)和乳房 X 光检查(OR:1.32,95%CI:1.02-1.71,p<0.05)的几率,与 2008 年观察到的几率一致。西班牙裔个体报告结直肠癌筛查率随时间推移有所改善,但 2018 年与非西班牙裔白人相比,无显著差异,尽管 2008 年报告的几率较低。与私人保险相比,2008 年和 2018 年,无保险状态与所有三种癌症的筛查几率显著降低相关。
尽管 2008 年至 2018 年间乳腺癌和结直肠癌筛查率总体有所增加,但种族/族裔和保险群体之间仍然存在种族/族裔和保险差异。这些发现强调了解决服务不足人群中存在的差异的重要性,并制定相应的干预措施。